Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease

  • Protocol
  • Intervention

Authors

  • Siheng Lin,

    1. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Department of Gastroenterology, Hangzhou, Zhejiang, China
    2. Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Guangzhou, Guangdong, China
    Search for more papers by this author
  • Kun Xiao,

    1. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Guangzhou, Guangdong, China
    Search for more papers by this author
  • Yangyang Liu,

    1. Zhiguang Biotechnology Limited Company, Department of Pharmaceutical Research and Development, Guangzhou, 510663, China
    Search for more papers by this author
  • Peizhu Su,

    1. Zhuangjiang Hospital, Southern Medical University, Department of Gastroenterology and Hepatology, Guangzhou, Guangdong, China
    Search for more papers by this author
  • Pingyan Chen,

    1. Southern Medical University, Department of Biostatistics, Guangzhou, Guangdong, China
    Search for more papers by this author
  • Yali Zhang,

    1. Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Guangzhou, Guangdong, China
    Search for more papers by this author
  • Yang Bai

    Corresponding author
    1. Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Guangzhou, Guangdong, China
    • Yang Bai, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, No.1838, Guangzhou North Avenue, Guangzhou, Guangdong, 510515, China. baiyangsmu@gmail.com.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the beneficial and harmful effects of omega-3 polyunsaturated fatty acids supplementation in people with non-alcoholic fatty liver disease.